CoreCap Advisors’s Annovis Bio ANVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.67K Hold
2,101
– – ﹤0.01% 2420
2026
Q2
$3.91K Hold
2,101
– – ﹤0.01% 2355
2026
Q1
$4.68K Buy
+2,101
New +$5.76K ﹤0.01% 2187

Other funds holding ANVS

CoreCap Advisors's ANVS Position: Q3 2026 in Review

CoreCap Advisors held its Annovis Bio (ANVS) position steady in Q3 2026 at 2,101 shares worth $2.67K. The position accounts for ﹤0.01% of the portfolio, ranked #2420.

CoreCap Advisors first reported a position in ANVS in Q1 2026 and has held it in 3 quarters since. The position peaked at $4.68K in Q1 2026. 2 funds tracked by Wall St. Rank hold ANVS as of Q3 2026.

  • CoreCap Advisors held 2,101 shares of Annovis Bio worth $2.67K as of Q3 2026.
  • CoreCap Advisors left its Annovis Bio share count unchanged in Q3 2026.
  • Annovis Bio made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2420 holding.
  • CoreCap Advisors first reported a position in Annovis Bio in Q1 2026 and has held it in 3 quarters since.
  • CoreCap Advisors's Annovis Bio position peaked at $4.68K in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Annovis Bio as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.